Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Understand the concept of compound interest on your investments and how it can lead to significant financial growth.
21,581 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
When a notable manager trims a stake in a popular ETF, it can offer clues about risk, opportunity, and the broader ma...
Retirees facing rising taxes must plan withdrawals carefully. With $2M in retirement accounts, a strategic advisor ca...
In a volatile market, a high-yield dividend stock demonstrates how investors can secure steady income. A $10,000 inve...
The U.S. public debt is approaching $50 trillion, pushing lawmakers and investors to re-evaluate fiscal promises and ...
When a high-quality dividend stock dives by more than a third, smart investors look beyond the fall. This guide break...
Deloitte has crowned NovaScroll as North America’s fastest-growing software company and the private firm is selling p...
Nvidia publicly praising Marvell Technology sparked a sharp price move and fresh debate about AI-driven growth. This ...
A little-known robotics ETF is trading at a discount, offering broad exposure as robotics ETFs will dominate in the c...
Retirement planning can feel overwhelming, and a tempting, seemingly simple move can backfire. Here’s how to spot hid...
As markets shift in May 2026, a popular plan to generate $4,800 per year from $40,000 in dividend stocks faces realit...
A major shift in early trading set the tone for Accenture's latest results. This article explains why accenture stock...